ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+5.35%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$235M
AUM Growth
+$46.1M
(+24%)
Cap. Flow
+$35.5M
Cap. Flow
% of AUM
15.07%
Top 10 Holdings %
Top 10 Hldgs %
46.57%
Holding
91
New
39
Increased
11
Reduced
15
Closed
22
Top Buys
| 1 |
VCRA
VOCERA COMMUNICATIONS, INC.
VCRA
|
$12.4M |
| 2 |
Bristol-Myers Squibb
BMY
|
$11.5M |
| 3 |
Gilead Sciences
GILD
|
$10.1M |
| 4 |
Takeda Pharmaceutical
TAK
|
$8.91M |
| 5 |
Icon
ICLR
|
$8.16M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$14.8M |
| 2 |
CELG
Celgene Corp
CELG
|
$10.8M |
| 3 |
SHPG
Shire pic
SHPG
|
$8.02M |
| 4 |
CVS Health
CVS
|
$7.36M |
| 5 |
DaVita
DVA
|
$7.24M |
Sector Composition
| 1 | Healthcare | 79.87% |
| 2 | Technology | 11.14% |
| 3 | Industrials | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
PTC Therapeutics
PTCT
$4.61B
| $636K | 0.25% |
+16,903
| New | +$636K |
|
52
Henry Schein
HSIC
$8.22B
| $631K | 0.25% |
+10,503
| New | +$631K |
|
|
53
CVS Health
CVS
$93.5B
| $595K | 0.24% |
11,036
-136,593
| -93% | -$7.36M |
|
54
Haemonetics
HAE
$2.61B
| $585K | 0.23% |
+6,691
| New | +$585K |
|
|
IMGN
55
DELISTED
Immunogen Inc
IMGN
| $500K | 0.2% |
+184,440
| New | +$500K |
|
56
VistaGen Therapeutics
VTGN
$111M
| $462K | 0.18% |
+12,031
| New | +$462K |
|
57
AnaptysBio
ANAB
$590M
| $444K | 0.18% |
6,082
-6,652
| -52% | -$486K |
|
58
Surgery Partners
SGRY
$2.87B
| $438K | 0.17% |
+38,805
| New | +$438K |
|
|
ARRY
59
DELISTED
Array Biopharma Inc
ARRY
| $401K | 0.16% |
16,447
-85,898
| -84% | -$2.09M |
|
|
BHVN
60
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $385K | 0.15% |
+7,479
| New | +$385K |
|
61
Dynavax Technologies
DVAX
$1.17B
| $302K | 0.12% |
+41,288
| New | +$302K |
|
|
GRTS
62
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $283K | 0.11% |
+21,257
| New | +$283K |
|
63
Aldeyra Therapeutics
ALDX
$332M
| $213K | 0.08% |
23,576
-43,063
| -65% | -$389K |
|
64
Accuray
ARAY
$170M
| – | – |
-455,018
| Closed | -$1.55M |
|
65
Axogen
AXGN
$709M
| – | – |
-39,961
| Closed | -$816K |
|
66
Boston Scientific
BSX
$159B
| – | – |
-30,560
| Closed | -$1.08M |
|
|
67
DaVita
DVA
$9.69B
| – | – |
-140,729
| Closed | -$7.24M |
|
68
Encompass Health
EHC
$12.5B
| – | – |
-107,187
| Closed | -$5.26M |
|
69
Amicus Therapeutics
FOLD
$2.47B
| – | – |
-58,240
| Closed | -$558K |
|
70
Hologic
HOLX
$14.8B
| – | – |
-135,805
| Closed | -$5.58M |
|
71
Iovance Biotherapeutics
IOVA
$796M
| – | – |
-318,185
| Closed | -$2.82M |
|
72
Johnson & Johnson
JNJ
$431B
| – | – |
-6,588
| Closed | -$850K |
|
73
PetMed Express
PETS
$62.8M
| – | – |
-67,010
| Closed | -$1.56M |
|
74
Insulet
PODD
$24.4B
| – | – |
-40,727
| Closed | -$3.23M |
|
75
Invesco QQQ Trust
QQQ
$368B
| – | – |
0
| – | – |
|